Industry Updates

Gen-Probe Amends Deal to Get Promising Test for Prostate Cancer | Xconomy30 Apr

Gen-Probe, one of my favorite local biotechs, agrees to cash infusions for Canadian partner DiagnoCure after very promising results on their new prostrate cancer diagnostic. The new diagnostic, which looks for gene PCA3 in urine, has the potential to reduce the high number of biopsies, false positives and unnecessary pain they cause.

http://www.xconomy.com/san-diego/2009/04/29/gen-probe-amends-deal-to-get-promising-test-for-prostate-cancer/

Leave a Reply

Company News

  • - 2013/03/04

    One of our team members is now working with Hospira on infuser product support. Contact us to find out more!

  • - 2010/10/24

    We're currently working with online elections provider Everyone Counts, Inc. Contact us to find out more!

Contact Us